Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001628280-25-040670

Director sold 7,086 shares at $8.87 ($62,853)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Zoon Kathryn C Director 2025-08-15 Sale 10b5-1 −7,086 $8.87 $62,853 71,799 D: show line 1 in the form
Open-market sales · 7,086 sh · avg $8.87 · $62,853
Loading xslF345X05/wk-form4_1755549206.xml…